GlassScriptPhysician profile
Thomas J Serey
NPI 1851398929
$8,611.88
in general payments reported to CMS, 2019-2025
51 companies · $943 in 2025
The $943 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,445 · 2020: $1,258 · 2021: $1,442 · 2022: $1,355 · 2023: $1,242 · 2024: $928 · 2025: $943.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,013 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,013.03 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $1,148.72 | 2019-2020 | |
| Teleflex LLC | $1,130.82 | 2020-2025 | Urolift |
| Coloplast Corp | $818.88 | 2019-2025 | Speedicath |
| Astellas Pharma US INC | $700.31 | 2019-2025 | Xtandi, Myrbetriq, Padcev |
| Janssen Biotech, INC. | $590.39 | 2019-2025 | Erleada, Akeega |
| Verathon INC. | $400.00 | 2021 | |
| Sumitomo Pharma America, INC. | $393.19 | 2023-2025 | Gemtesa, Orgovyx |
| Boston Scientific Corporation | $357.71 | 2019-2025 | Lithovue, Advance Xp, Xpeeda Dsl Fiber |
| Bayer Healthcare Pharmaceuticals INC. | $258.82 | 2019-2025 | |
| Procept Biorobotics Corporation | $219.53 | 2019-2025 | Aquabeam Robotic System |
| Abbvie INC. | $212.23 | 2019-2025 | Lupron Depot |
| Myriad Genetic Laboratories, INC. | $198.30 | 2023-2025 | Prolaris |
| Merck Sharp & Dohme LLC | $167.24 | 2020-2025 | Keytruda |
| Antares Pharma, INC. | $150.73 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Amgen INC. | $134.27 | 2019-2021 |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Serey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.